We have found significantly lower tissue levels of IL-6, IL-17A, IL-23 and IL-10 in CHC-NSF in comparison with the NASH group, despite the same level of fibrosis in these two groups (F0/F1/F2). This evidence concerns the gene IL10 and metabolic dysfunction-associated steatohepatitis.